Skip to main content

Table 2 Patients switched to ETV with a detectable viral load

From: Etravirine use in clinical practice: 48-week data from a single centre cohort

VL< 50 copies/ml 12 weeks (n = 52) 24 weeks (n = 44) 36 weeks (n = 33) 48 weeks (n = 25)
Intention to treat 65% 73% 70% 76%
On treatment 71% 84% 79% 90%